|
original article |
Journal |
Date |
Title |
Authors All Authors |
1 |
[GO] |
EMBO Molecular Medicine |
2023―Nov―15 |
Acquired immunity against SARS-CoV-2 infection and vaccination |
Laurent Renia, Lisa FP Ng |
2 |
[GO] |
EMBO Molecular Medicine |
2023―Aug―03 |
Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection |
Liqiang Zhang, Yize (Henry) Li, Karen Kibler, Simona Kraberger, Arvind Varsani, Julie Turk, et al. (+26) Nora Elmadbouly, Emily Aliskevich, Laurel Spaccarelli, Bereket Estifanos, Junior Enow, Isabela Rivabem Zanetti, Nicholas Saldevar, Efrem Lim, Jessika Schlievert, Kyle Browder, Anjali Wilson, Fernando Arcos Juan, Aubrey Pinteric, Aman Garg, Henna Monder, Rohan Saju, Savanah Gisriel, Bertram Jacobs, Timothy L Karr, Esther Borges Florsheim, Vivek Kumar, John Wallen, Masmudur Rahman, Grant McFadden, Brenda G Hogue, Alexandra R Lucas |
3 |
[GO] |
EMBO Molecular Medicine |
2023―Jul―31 |
Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation |
Lisa Schweizer, Tina Schaller, Maximilian Zwiebel, Özge Karayel, Johannes Bruno Müller-Reif, Wen-Feng Zeng, et al. (+6) Sebastian Dintner, Thierry M Nordmann, Klaus Hirschbühl, Bruno Märkl, Rainer Claus, Matthias Mann |
4 |
[GO] |
EMBO Molecular Medicine |
2023―May―22 |
Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc |
Pei-Shan Sung, Cheng-Pu Sun, Mi-Hua Tao, Shie-Liang Hsieh |
5 |
[GO] |
EMBO Molecular Medicine |
2023―Mar―22 |
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses |
Valeria Fumagalli, Pietro Di Lucia, Micol Ravà, Davide Marotta, Elisa Bono, Stefano Grassi, et al. (+15) Lorena Donnici, Rolando Cannalire, Irina Stefanelli, Anastasia Ferraro, Francesca Esposito, Elena Pariani, Donato Inverso, Camilla Montesano, Serena Delbue, Stanley Perlman, Enzo Tramontano, Raffaele De Francesco, Vincenzo Summa, Luca G Guidotti, Matteo Iannacone |
6 |
[GO] |
EMBO Molecular Medicine |
2022―Sep―12 |
An
ACE2
decoy can be administered by inhalation and potently targets omicron variants of
SARS-CoV
-2 |
Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, Kui K. Chan, Savanna S. Skeeters, Christine A. Devlin, et al. (+6) Aaron Aguhob, Kristie Shirley, Lijun Rong, Jalees Rehman, Asrar B. Malik, Erik Procko |
7 |
[GO] |
EMBO Molecular Medicine |
2022―Aug―20 |
A universal
SARS-CoV DNA
vaccine inducing highly crossreactive neutralizing antibodies and T cells |
Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia Larsson, et al. (+14) Urban Höglund, Soo Aleman, Friedemann Weber, Emma Perlhamre, Johanna Apro, Eva-Karin Gidlund, Ola Tuvesson, Simona Salati, Matteo Cadossi, Hanna Tegel, Sophia Hober, Lars Frelin, Ali Mirazimi, Matti Sallberg |
8 |
[GO] |
EMBO Molecular Medicine |
2022―Jul―27 |
SARS-CoV
-2 spike protein enhances
MAP4K3
/
GLK
-induced
ACE2
stability in
COVID
-19 |
Huai-Chia Chuang, Chia-Hsin Hsueh, Pu-Ming Hsu, Rou-Huei Huang, Ching-Yi Tsai, Nai-Hsiang Chung, et al. (+2) Yen-Hung Chow, Tse-Hua Tan |
9 |
[GO] |
EMBO Molecular Medicine |
2022―Jul―04 |
Clinical grade
ACE2
as a universal agent to block
SARS-CoV
-2 variants |
Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, et al. (+29) Franz Kricek, Janine Niederhöfer, Alice Schwarzböck, Helene Breid, Stephanie Devignot, Jonas Klingström, Charlotte Thålin, Max J Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska-Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M Penninger |
10 |
[GO] |
EMBO Molecular Medicine |
2022―Jul―04 |
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination |
Sebastian J Theobald, Alexander Simonis, Julie M Mudler, Ulrike Göbel, Richard Acton, Viktoria Kohlhas, et al. (+9) Marie-Christine Albert, Anna-Maria Hellmann, Jakob J Malin, Sandra Winter, Michael Hallek, Henning Walczak, Phuong-Hien Nguyen, Manuel Koch, Jan Rybniker |
11 |
[GO] |
EMBO Molecular Medicine |
2022―Jul―01 |
A novel platform for attenuating immune hyperactivity using
EXO-CD24
in Covid-19 and beyond |
Shiran Shapira, Marina Ben Shimon, Mori Hay-Levi, Gil Shenberg, Guy Choshen, Lian Bannon, et al. (+9) Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev-Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber |
12 |
[GO] |
EMBO Molecular Medicine |
2022―May―17 |
Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells |
Marina Chan, Eric C Holland, Taranjit S Gujral |
13 |
[GO] |
EMBO Molecular Medicine |
2022―Apr―01 |
SARS-CoV-2 Spike Spurs Intestinal Inflammation via VEGF Production in Enterocytes |
Fa-min Zeng, Ying-wen Li, Zhao-hua Deng, Jian-zhong He, Wei Li, Lijie Wang, et al. (+12) Ting Lyu, Zhanyu Li, Chaoming Mei, Meiling Yang, Ying-ying Dong, Guan-Min Jiang, Xiaofeng Li, Xi Huang, Fei Xiao, Ye Liu, Hong Shan, Huanhuan He |
14 |
[GO] |
EMBO Molecular Medicine |
2022―Mar―14 |
RNAi to treat SARS-CoV-2-variant proofing the next generation of therapies |
Nigel A J McMillan, Kevin V Morris, Adi Idris |
15 |
[GO] |
EMBO Molecular Medicine |
2022―Feb―25 |
COVID-19 vaccination, time for a second breath? |
Christiane E Gerke, Bernd Pulverer, Philippe J Sansonetti |
16 |
[GO] |
EMBO Molecular Medicine |
2022―Feb―09 |
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant |
Yi-Chung Chang, Chi-Fan Yang, Yi-Fen Chen, Chia-Chun Yang, Yuan-Lin Chou, Hung-Wen Chou, et al. (+18) Tein-Yao Chang, Tai-Ling Chao, Shu-Chen Hsu, Si-Man Ieong, Ya-Min Tsai, Ping-Cheng Liu, Yuan-Fan Chin, Jun-Tung Fang, Han-Chieh Kao, Hsuan-Ying Lu, Jia-Yu Chang, Ren-Shiuan Weng, Qian-Wen Tu, Fang-Yu Chang, Kuo-Yen Huang, Tong-Young Lee, Sui-Yuan Chang, Pan-Chyr Yang |
17 |
[GO] |
EMBO Molecular Medicine |
2022―Jan―27 |
SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance |
Xavier Montagutelli, Sylvie van der Werf, Felix A Rey, Etienne Simon-Loriere |
18 |
[GO] |
EMBO Molecular Medicine |
2022―Jan―07 |
Decreased memory B cells frequencies in COVID-19 Delta variant vaccine breakthrough infection |
Matthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, Yun Shan Goh, Yi-Hao Chan, Zi Wei Chang, et al. (+24) Weili Xu, Chee Wah Tan, Wan Ni Chia, Anthony Torres-Ruesta, Siti Naqiah Amrun, Yuling Huang, Pei Xiang Hor, Chiew Yee Loh, Nicholas Kim-Wah Yeo, Bei Wang, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Jean-Marc Chavatte, Alicia Jieling Lim, Sebastian Maurer-Stroh, Lin-Fa Wang, Raymond TP Lin, Cheng-I Wang, Seow-Yen Tan, Barnaby Edward Young, Yee-Sin Leo, David C Lye, Laurent Renia, Lisa F P Ng |
19 |
[GO] |
EMBO Molecular Medicine |
2021―Dec―04 |
Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Samples |
Emily A. Bruce, Margaret G. Mills, Reigran Sampoleo, Garrett A. Perchetti, Meei-Li Huang, Hannah W. Despres, et al. (+6) Madaline M. Schmidt, Pavitra Roychoudhury, David J. Shirley, Keith R. Jerome, Alexander L. Greninger, Jason W. Botten |
20 |
[GO] |
EMBO Molecular Medicine |
2021―Nov―08 |
High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection |
Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti |
21 |
[GO] |
EMBO Molecular Medicine |
2021―Oct―21 |
Flower lose, a cell fitness marker, predicts COVID-19 prognosis |
Michail Yekelchyk, Esha Madan, Jochen Wilhelm, Kirsty R Short, António M Palma, Linbu Liao, et al. (+37) Denise Camacho, Everlyne Nkadori, Michael T Winters, Emily S Rice, Inês Rolim, Raquel Cruz-Duarte, Christopher J Pelham, Masaki Nagane, Kartik Gupta, Sahil Chaudhary, Thomas Braun, Raghavendra Pillappa, Mark S Parker, Thomas Menter, Matthias Matter, Jasmin Dionne Haslbauer, Markus Tolnay, Kornelia D Galior, Kristina A Matkwoskyj, Stephanie M McGregor, Laura K Muller, Emad A Rakha, Antonio Lopez-Beltran, Ronny Drapkin, Maximilian Ackermann, Paul B Fisher, Steven R Grossman, Andrew K Godwin, Arutha Kulasinghe, Ivan Martinez, Clay B Marsh, Benjamin Tang, Max S Wicha, Kyoung Jae Won, Alexandar Tzankov, Eduardo Moreno, Rajan Gogna |
22 |
[GO] |
EMBO Molecular Medicine |
2021―Oct―21 |
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody |
Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Hebang Yao, et al. (+29) Liu Daisy Liu, Zhou Sun, Martje Fentener van Vlissingen, Thijs Kuiken, Corine H. GeurtsvanKessel, Ning Zhang, Bingjie Zhou, Lu Lu, Yuhuan Gong, Wenming Qin, Moumita Mondal, Bowen Duan, Shiqi Xu, Audrey S Richard, Hervé Raoul, JianFeng Chen, Chenqi Xu, Ligang Wu, Haisheng Zhou, Zhong Huang, Xuechao Zhang, Jun Li, Yanyan Wang, Yuhai Bi, Barry Rockx, Junfang Chen, Fei-Long Meng, Dimitri Lavillette, Dianfan Li |
23 |
[GO] |
EMBO Molecular Medicine |
2021―Oct―16 |
Brain Cross-Protection against SARS-CoV-2 Variants by a Lentiviral Vaccine in New Transgenic Mice |
Min-Wen Ku, Pierre Authié, Maryline Bourgine, François Anna, Amandine Noirat, Fanny Moncoq, et al. (+15) Benjamin Vesin, Fabien Nevo, Jodie Lopez, Philippe Souque, Catherine Blanc, Ingrid Fert, Sébastien Chardenoux, llta Lafosse, Delphine Cussigh, David Hardy, Kirill Nemirov, Françoise Guinet, Francina Langa Vives, Laleh Majlessi, Pierre Charneau |
24 |
[GO] |
EMBO Molecular Medicine |
2021―Sep―17 |
Racing for a SARS-CoV-2 vaccine |
Özlem Türeci, Uğur Şahin |
25 |
[GO] |
EMBO Molecular Medicine |
2021―Jul―14 |
Individual COVID-19 disease trajectories revealed by plasma proteomics |
Danish Memon, Inigo Barrio-Hernandez, Pedro Beltrao |
26 |
[GO] |
EMBO Molecular Medicine |
2021―Jul―07 |
High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion |
Philipp E Geyer, Florian M Arend, Sophia Doll, Marie-Luise Louiset, Sebastian Virreira Winter, Johannes B Müller-Reif, et al. (+8) Furkan M Torun, Michael Weigand, Peter Eichhorn, Mathias Bruegel, Maximilian T Strauss, Lesca M Holdt, Matthias Mann, Daniel Teupser |
27 |
[GO] |
EMBO Molecular Medicine |
2021―Jun―25 |
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin |
Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, Lena Feige, Etienne Kornobis, Sylvain Levallois, et al. (+9) Agnès Marchio, Lauriane Kergoat, David Hardy, Thomas Cokelaer, Pascal Pineau, Marc Lecuit, Pierre-Marie Lledo, Jean-Pierre Changeux, Hervé Bourhy |
28 |
[GO] |
EMBO Molecular Medicine |
2021―Jun―16 |
Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19 |
Sebastian J Theobald, Alexander Simonis, Theodoros Georgomanolis, Christoph Kreer, Matthias Zehner, Hannah S Eisfeld, et al. (+27) Marie-Christine Albert, Jason Chhen, Susanne Motameny, Florian Erger, Julia Fischer, Jakob J Malin, Jessica Gräb, Sandra Winter, Andromachi Pouikli, Friederike David, Boris Böll, Philipp Koehler, Kanika Vanshylla, Henning Gruell, Isabelle Suárez, Michael Hallek, Gerd Fätkenheuer, Norma Jung, Oliver A Cornely, Clara Lehmann, Peter Tessarz, Janine Altmüller, Peter Nürnberg, Hamid Kashkar, Florian Klein, Manuel Koch, Jan Rybniker |
29 |
[GO] |
EMBO Molecular Medicine |
2021―May―09 |
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 |
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, Guillaume Carissimo, Nicholas Kim-Wah Yeo, Siti Naqiah Amrun, et al. (+20) Yun Shan Goh, Jackwee Lim, Weili Xu, Rhonda Sin-Ling Chee, Anthony Torres-Ruesta, Cheryl Yi-Pin Lee, Matthew Zirui Tay, Zi Wei Chang, Wen-Hsin Lee, Bei Wang, Seow-Yen Tan, Shirin Kalimuddin, Barnaby Edward Young, Yee-Sin Leo, Cheng-I Wang, Bernett Lee, Olaf Rötzschke, David Chien Lye, Laurent Renia, Lisa F.P. Ng |
30 |
[GO] |
EMBO Molecular Medicine |
2021―May―01 |
SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course Study - Potential Challenge for Vaccines and Therapies |
Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler |
31 |
[GO] |
EMBO Molecular Medicine |
2021―Mar―31 |
High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection |
Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti |
32 |
[GO] |
EMBO Molecular Medicine |
2021―Feb―06 |
Epithelial response to IFN-γ promotes SARS-CoV-2 infection |
Julian Heuberger, Jakob Trimpert, Daria Vladimirova, Christian Goosmann, Manqiang Lin, Rosa Schmuck, et al. (+5) Hans-Joachim Mollenkopf, Volker Brinkmann, Frank Tacke, Nikolaus Osterrieder, Michael Sigal |
33 |
[GO] |
EMBO Molecular Medicine |
2021―Jan―20 |
Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein |
Lydia Horndler, Pilar Delgado, David Abia, Ivaylo Balabanov, Pedro Martínez-Fleta, Georgina Cornish, et al. (+6) Miguel A. Llamas, Sergio Serrano-Villar, Francisco Sánchez-Madrid, Manuel Fresno, Hisse M. van Santen, Balbino Alarcón |
34 |
[GO] |
EMBO Molecular Medicine |
2020―Dec―17 |
The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections |
Hugh Rosen, Michael B A Oldstone |
35 |
[GO] |
EMBO Molecular Medicine |
2020―Nov―15 |
Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19 |
Giovanni Marfia, Stefania Navone, Laura Guarnaccia, Rolando Campanella, Michele Mondoni, Marco Locatelli, et al. (+9) Alessandra Barassi, Laura Fontana, Fabrizio Palumbo, Emanuele Garzia, Giuseppe Ciniglio Appiani, Davide Chiumello, Monica Miozzo, Stefano Centanni, Laura Riboni |
36 |
[GO] |
EMBO Molecular Medicine |
2020―Nov―12 |
Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection |
Vanessa Monteil, Matheus Dyczynski, Volker M Lauschke, Hyesoo Kwon, Gerald Wirnsberger, Sonia Youhanna, et al. (+7) Haibo Zhang, Arthur S.Slutsky, Carmen Hurtado del Pozo, Moritz Horn, Nuria Montserrat, Josef M. Penninger, Ali Mirazimi |
37 |
[GO] |
EMBO Molecular Medicine |
2020―Nov―07 |
Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection |
Kuo-Yen Huang, Ming-Shiu Lin, Ting-Chun Kuo, Ci-Ling Chen, Chung-Chih Lin, Yu-Chi Chou, et al. (+7) Tai-Ling Chao, Yu-Hao Pang, Han-Chieh Kao, Rih-Sheng Huang, Steven Lin, Sui-Yuan Chang, Pan-Chyr Yang |
38 |
[GO] |
EMBO Molecular Medicine |
2020―Oct―20 |
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia |
Lara Gibellini, Sara De Biasi, Annamaria Paolini, Rebecca Borella, Federica Boraldi, Marco Mattioli, et al. (+14) Domenico Lo Tartaro, Lucia Fidanza, Alfredo Caro-Maldonado, Marianna Meschiari, Vittorio Iadisernia, Erica Bacca, Giovanni Riva, Luca Cicchetti, Daniela Quaglino, Giovanni Guaraldi, Stefano Busani, Massimo Girardis, Cristina Mussini, Andrea Cossarizza |
39 |
[GO] |
EMBO Molecular Medicine |
2020―Oct―19 |
COVID
-19 pandemic-related lockdown: response time is more important than its strictness |
Gil Loewenthal, Shiran Abadi, Oren Avram, Keren Halabi, Noa Ecker, Natan Nagar, et al. (+2) Itay Mayrose, Tal Pupko |
40 |
[GO] |
EMBO Molecular Medicine |
2020―Oct―05 |
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2 |
Alexander Simonis, Sebastian J. Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J. Malin |
41 |
[GO] |
EMBO Molecular Medicine |
2020―Oct―04 |
SARS-CoV-2 outbreak investigation in a German meat processing plant |
Thomas Günther, Manja Czech-Sioli, Daniela Indenbirken, Alexis Robitaille, Peter Tenhaken, Martin Exner, et al. (+4) Matthias Ottinger, Nicole Fischer, Adam Grundhoff, Melanie M. Brinkmann |
42 |
[GO] |
EMBO Molecular Medicine |
2020―Sep―30 |
COVID-19: A Pandemic Experience that Illuminates Potential Reforms to Health Research |
Hannah N. Kozlowski, Michael E. Farkouh, Meredith S. Irwin, Laszlo G. Radvanyi, Aaron D. Schimmer, Uri Tabori, Norman D. Rosenblum |
43 |
[GO] |
EMBO Molecular Medicine |
2020―Aug―20 |
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes |
Fawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, et al. (+9) Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trecan, Ronan Roussel, Jean-Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean-François Gautier |
44 |
[GO] |
EMBO Molecular Medicine |
2020―Jun―23 |
Can artificial intelligence identify effective COVID-19 therapies? |
Michael B. Schultz, Daniel Vera, David A. Sinclair |
45 |
[GO] |
EMBO Molecular Medicine |
2020―Jun―19 |
Rationale for targeting Complement in COVID-19 |
Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, et al. (+2) Linda S Klavinskis, Steven Sacks |
46 |
[GO] |
EMBO Molecular Medicine |
2020―Jun―19 |
Autopsy registry can facilitate COVID-19 research |
Saskia von Stillfried, Roman David Bülow, Rainer Röhrig, Ruth Knüchel-Clarke, Peter Boor |
47 |
[GO] |
EMBO Molecular Medicine |
2020―May―30 |
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients |
Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J. Richardson, et al. (+16) Vanessa Monteil, Volker M. Lauschke, Ali Mirazimi, Sonia Youhanna, Yee-Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge A. Ross Terres, Brian J. Nickoloff, Richard E. Higgs, Guilherme Rocha, Nicole L. Byers, Douglas E. Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino |
48 |
[GO] |
EMBO Molecular Medicine |
2020―May―19 |
The role of interleukin-6 in monitoring severe case of coronavirus disease 2019 |
Tao Liu, Jieying Zhang, Yuhui Yang, Hong Ma, Zhenyu Li, Jiaoyue Zhang, et al. (+7) Ji Cheng, Xiaoyun Zhang, Yanxia Zhao, Zihan Xia, Liling Zhang, Gang Wu, Jianhua Yi |
49 |
[GO] |
EMBO Molecular Medicine |
2020―May―07 |
Is BCG vaccination causally related to reduced COVID-19 mortality? |
Masayuki Miyasaka |
50 |
[GO] |
EMBO Molecular Medicine |
2020―May―06 |
‘All In’: A Pragmatic Framework for COVID-19 Testing and Action on a Global Scale |
SD Pettit, KR Jerome, D Rouquie, B Mari, P Barbry, Y Kanda, et al. (+5) M Matsumoto, S Hester, L Wehmas, JW Botten, EA Bruce |
51 |
[GO] |
EMBO Molecular Medicine |
2020―Apr―25 |
COVID-19: lambda interferon against viral load and hyperinflammation |
Evangelos Andreakos, Sotirios Tsiodras |
52 |
[GO] |
EMBO Molecular Medicine |
2020―Apr―20 |
COVID-19, chronicle of an expected pandemic |
Philippe Sansonetti |
53 |
[GO] |
EMBO Molecular Medicine |
2020―Apr―17 |
The prospects for the SARS-CoV-2 pandemic in Africa |
Virginia Quaresima, Matteo M. Naldini, Daniela M. Cirillo |
54 |
[GO] |
EMBO Reports |
2023―Nov―02 |
Antibody-mediated SARS-CoV-2 entry in cultured cells |
Md Golam Kibria, Christy L Lavine, Weichun Tang, Shaowei Wang, Hailong Gao, Wei Shi, et al. (+11) Haisun Zhu, Jewel Voyer, Sophia Rits-Volloch, Keerti, Caihong Bi, Hanqin Peng, Duane R Wesemann, Jianming Lu, Hang Xie, Michael S Seaman, Bing Chen |
55 |
[GO] |
EMBO Reports |
2023―Oct―23 |
ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS |
Martin Müller, Alexandra Herrmann, Shigeru Fujita, Keiya Uriu, Carolin Kruth, Adam Strange, et al. (+8) Jan E Kolberg, Markus Schneider, Jumpei Ito, Marcel A Müller, Christian Drosten, Armin Ensser, Kei Sato, Daniel Sauter |
56 |
[GO] |
EMBO Reports |
2023―Oct―12 |
Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children |
Vladimir G Magalhães, Sören Lukassen, Maike Drechsler, Jennifer Loske, Sandy S Burkart, Sandra Wüst, et al. (+9) Eva-Maria Jacobsen, Jobst Röhmel, Marcus A Mall, Klaus-Michael Debatin, Roland Eils, Stella Autenrieth, Aleš Janda, Irina Lehmann, Marco Binder |
57 |
[GO] |
EMBO Reports |
2023―Oct―12 |
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release |
Hazel Stewart, Roberta Palmulli, Kristoffer H Johansen, Naomi McGovern, Ola M Shehata, George W Carnell, et al. (+9) Hannah K Jackson, Jin S Lee, Jonathan C Brown, Thomas Burgoyne, Jonathan L Heeney, Klaus Okkenhaug, Andrew E Firth, Andrew A Peden, James R Edgar |
58 |
[GO] |
EMBO Reports |
2023―May―15 |
Antiviral activity of the human endogenous retrovirus-R envelope protein against SARS-CoV-2 |
Shabnam Ansari, Nidhi Gupta, Rohit Verma, Oinam N Singh, Jyoti Gupta, Amit Kumar, et al. (+11) Mukesh Kumar Yadav, Akshay Binayke, Mahima Tiwari, Neha Periwal, Vikas Sood, Shailendra Mani, Amit Awasthi, Shalimar, Baibaswata Nayak, CT Ranjith-Kumar, Milan Surjit |
59 |
[GO] |
EMBO Reports |
2023―Mar―23 |
Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparedness |
Dan Lou, Matthias Meurer, Svetlana Ovchinnikova, Robin Burk, Anna Denzler, Konrad Herbst, et al. (+23) Ioannis A Papaioannou, Yuanqiang Duan, Max L Jacobs, Victoria Witte, Daniel Ürge, Daniel Kirrmaier, Michelle Krogemann, Krisztina Gubicza, Kathleen Boerner, Christian Bundschuh, Niklas M Weidner, Uta Merle, Britta Knorr, Andreas Welker, Claudia M Denkinger, Paul Schnitzler, Hans-Georg Kräusslich, Viet Loan Dao Thi, Manuela De Allegri, Hoa Thi Nguyen, Andreas Deckert, Simon Anders, Michael Knop |
60 |
[GO] |
EMBO Reports |
2023―Mar―07 |
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice |
Adam D Kenney, Ashley Zani, Jeffrey Kawahara, Adrian C Eddy, Xiao-Liang Wang, KC Mahesh, et al. (+12) Mijia Lu, Jeronay Thomas, Jacob E Kohlmeier, Mehul S Suthar, Emily A Hemann, Jianrong Li, Mark E Peeples, Luanne Hall-Stoodley, Adriana Forero, Chuanxi Cai, Jianjie Ma, Jacob S Yount |
61 |
[GO] |
EMBO Reports |
2023―Mar―06 |
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19 |
Sarah Temmam, Xavier Montagutelli, Cécile Herate, Flora Donati, Béatrice Regnault, Mikael Attia, et al. (+19) Eduard Baquero Salazar, Delphine Chretien, Laurine Conquet, Grégory Jouvion, Juliana Pipoli Da Fonseca, Thomas Cokelaer, Faustine Amara, Francis Relouzat, Thibaut Naninck, Julien Lemaitre, Nathalie Derreudre-Bosquet, Quentin Pascal, Massimiliano Bonomi, Thomas Bigot, Sandie Munier, Felix A Rey, Roger Le Grand, Sylvie van der Werf, Marc Eloit |
62 |
[GO] |
EMBO Reports |
2023―Mar―06 |
Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection |
Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, et al. (+9) Xinhua Cao, Ying Miao, Yukang Yuan, Yanli Liu, Feng Ma, Jianfeng Dai, Sheng Tian, Qiang Ding, Hui Zheng |
63 |
[GO] |
EMBO Reports |
2023―Mar―06 |
Low hanging fruit for combatting SARS-CoV-2? |
Diego Cantoni, Joe Grove |
64 |
[GO] |
EMBO Reports |
2022―Oct―26 |
Nsp16 shields
SARS-CoV
-2 from efficient
MDA5
sensing and
IFIT1
-mediated restriction |
Alina Russ, Sabine Wittmann, Yuta Tsukamoto, Alexandra Herrmann, Janina Deutschmann, Justine Lagisquet, et al. (+3) Armin Ensser, Hiroki Kato, Thomas Gramberg |
65 |
[GO] |
EMBO Reports |
2022―Aug―24 |
Evolutionary remodelling of N-terminal domain loops fine-tunes
SARS-CoV
-2 spike |
Diego Cantoni, Matthew J. Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, et al. (+24) Spyros Lytras, Jonathon D. Coey, James McKenna, Stephen Bridgett, David Simpson, Derek Fairley, Lucy G. Thorne, Ann-Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Machaela Palor, Lisa Jarvis, Brian Willett, Ultan F. Power, Laura E. McCoy, Clare Jolly, Greg J. Towers, Katie J. Doores, David L. Robertson, Adrian J. Shepherd, Matthew B. Reeves, Connor G. G. Bamford, Joe Grove |
66 |
[GO] |
EMBO Reports |
2022―Aug―16 |
Impaired activation of transposable elements in
SARS-CoV
-2 infection |
Matan Sorek, Eran Meshorer, Sharon Schlesinger |
67 |
[GO] |
EMBO Reports |
2022―Jul―28 |
After 2 years of a pandemic, students are struggling to find strong reference letters |
David R Smith |
68 |
[GO] |
EMBO Reports |
2022―May―12 |
Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch |
Ilaria Callegari, Mika Schneider, Giuliano Berloffa, Tobias Mühlethaler, Sebastian Holdermann, Edoardo Galli, et al. (+9) Tim Roloff, Renate Boss, Laura Infanti, Nina Khanna, Adrian Egli, Andreas Buser, Gert Zimmer, Tobias Derfuss, Nicholas S R Sanderson |
69 |
[GO] |
EMBO Reports |
2022―May―09 |
ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion |
Georg Jocher, Vincent Grass, Sarah K Tschirner, Lydia Riepler, Stephan Breimann, Tuğberk Kaya, et al. (+11) Madlen Oelsner, M Sabri Hamad, Laura I Hofmann, Carl P Blobel, Carsten B Schmidt-Weber, Ozgun Gokce, Constanze A Jakwerth, Jakob Trimpert, Janine Kimpel, Andreas Pichlmair, Stefan F Lichtenthaler |
70 |
[GO] |
EMBO Reports |
2022―Apr―25 |
A human coronavirus OC43-derived polypeptide causes neuropathic pain |
Veronica I Shubayev, Jennifer Dolkas, Glaucilene Ferreira Catroli, Andrei V Chernov |
71 |
[GO] |
EMBO Reports |
2022―Mar―07 |
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance |
Justin D Walter, Melanie Scherer, Cedric A J Hutter, Alisa A Garaeva, Iwan Zimmermann, Marianne Wyss, et al. (+17) Jan Rheinberger, Yelena Ruedin, Jennifer C Earp, Pascal Egloff, Michèle Sorgenfrei, Lea M Hürlimann, Imre Gonda, Gianmarco Meier, Sille Remm, Sujani Thavarasah, Geert van Geest, Rémy Bruggmann, Gert Zimmer, Dirk J Slotboom, Cristina Paulino, Philippe Plattet, Markus A Seeger |
72 |
[GO] |
EMBO Reports |
2022―Mar―03 |
A simple reverse genetics method to generate recombinant coronaviruses |
Julien Mélade, Géraldine Piorkowski, Franck Touret, Toscane Fourié, Jean-Sélim Driouich, Maxime Cochin, et al. (+4) Hawa Sophia Bouzidi, Bruno Coutard, Antoine Nougairède, Xavier Lamballerie |
73 |
[GO] |
EMBO Reports |
2022―Feb―23 |
Lamarck redux and other false arguments against SARS-CoV-2 vaccination |
Emanuel Goldman |
74 |
[GO] |
EMBO Reports |
2021―Dec―20 |
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern |
Teresa R Wagner, Daniel Schnepf, Julius Beer, Natalia Ruetalo, Karin Klingel, Philipp D Kaiser, et al. (+10) Daniel Junker, Martina Sauter, Bjoern Traenkle, Desiree I Frecot, Matthias Becker, Nicole Schneiderhan-Marra, Annette Ohnemus, Martin Schwemmle, Michael Schindler, Ulrich Rothbauer |
75 |
[GO] |
EMBO Reports |
2021―Dec―16 |
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection |
Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, et al. (+9) Marco Vignuzzi, Sylvie van der Werf, Sylvie Behillil, Flora Donati, Nathalie Sauvonnet, Giulia Nigro, Maryline Bourgine, Nolwenn Jouvenet, Germano Cecere |
76 |
[GO] |
EMBO Reports |
2021―Dec―02 |
DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging |
Sara Sepe, Francesca Rossiello, Valeria Cancila, Fabio Iannelli, Valentina Matti, Giada Cicio, et al. (+8) Matteo Cabrini, Eugenia Marinelli, Busola R Alabi, Alessia di Lillo, Arianna Di Napoli, Jerry W Shay, Claudio Tripodo, Fabrizio d’Adda di Fagagna |
77 |
[GO] |
EMBO Reports |
2021―Sep―17 |
Lessons from COVID-19 |
Philip Hunter |
78 |
[GO] |
EMBO Reports |
2021―Sep―07 |
How many animals are used for SARS-CoV-2 research? |
Philipp Schwedhelm, Johanna Kusnick, Céline Heinl, Gilbert Schönfelder, Bettina Bert |
79 |
[GO] |
EMBO Reports |
2021―Sep―03 |
COVID-19 and the gain of function debates |
Kelsey Lane Warmbrod, Michael G Montague, Gigi Kwik Gronvall |
80 |
[GO] |
EMBO Reports |
2021―May―25 |
The COVID-19 pandemic: agile versus blundering communication during a worldwide crisis |
Gaby-Fleur Böl |
81 |
[GO] |
EMBO Reports |
2021―Apr―28 |
Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-chip model |
Vivek V Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet-Dessimoz, John D McKinney |
82 |
[GO] |
EMBO Reports |
2021―Apr―27 |
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies |
Teresa R Wagner, Elena Ostertag, Philipp D Kaiser, Marius Gramlich, Natalia Ruetalo, Daniel Junker, et al. (+17) Julia Haering, Bjoern Traenkle, Matthias Becker, Alex Dulovic, Helen Schweizer, Stefan Nueske, Armin Scholz, Anne Zeck, Katja Schenke-Layland, Annika Nelde, Monika Strengert, Juliane S Walz, Georg Zocher, Thilo Stehle, Michael Schindler, Nicole Schneiderhan-Marra, Ulrich Rothbauer |
83 |
[GO] |
EMBO Reports |
2021―Mar―24 |
COVID-19 and the opportunities for research |
Philip Hunter |
84 |
[GO] |
EMBO Reports |
2021―Feb―22 |
A CRISPR response to pandemics? |
Federico Germani, Sebastian Wäscher, Nikola Biller-Andorno |
85 |
[GO] |
EMBO Reports |
2020―Oct―28 |
SARS-CoV-2 evades immune detection in alveolar macrophages |
Louise Dalskov, Michelle Møhlenberg, Jacob Thyrsted, Julia Blay-Cadanet, Ebbe Toftgaard Poulsen, Birgitte Holst Folkersen, et al. (+7) Søren Helbo Skaarup, David Olagnier, Line Reinert, Jan Johannes Enghild, Hans Jürgen Hoffmann, Christian Kanstrup Holm, Rune Hartmann |
86 |
[GO] |
EMBO Reports |
2020―Aug―12 |
Data protection during the coronavirus crisis |
Christophe Olivier Schneble, Bernice Simone Elger, David Martin Shaw |
87 |
[GO] |
EMBO Reports |
2020―Mar―17 |
The spread of the
COVID
-19 coronavirus |
Philip Hunter |
88 |
[GO] |
Molecular Systems Biology |
2023―Mar―15 |
A methylation clock model of mild
SARS-CoV
-2 infection provides insight into immune dysregulation |
Weiguang Mao, Clare M Miller, Venugopalan D Nair, Yongchao Ge, Mary Anne S Amper, Antonio Cappuccio, et al. (+32) Mary-Catherine George, Carl W Goforth, Kristy Guevara, Nada Marjanovic, German Nudelman, Hanna Pincas, Irene Ramos, Rachel S G Sealfon, Alessandra Soares-Schanoski, Sindhu Vangeti, Mital Vasoya, Dawn L Weir, Elena Zaslavsky, Vanessa Barcessat, Kevin Tuballes, Diane Marie Del Valle, Kai Nie, Hui Xie, Grace Chung, Manishkumar Patel, Jocelyn Harris, Kimberly Argueta, Jacques Fehr, Barr Gruberg, Nicholas Zaki, Seunghee Kim-Schulze, Sacha Gnjatic, Miriam Merad, Andrew G Letizia, Olga G Troyanskaya, Stuart C Sealfon, Maria Chikina |
89 |
[GO] |
Molecular Systems Biology |
2022―Sep―12 |
Monocyte-crosstalk drives interferon-mediated signaling following
SARS-CoV
-2 exposure |
Sebastian J Theobald, Jan Rybniker |
90 |
[GO] |
Molecular Systems Biology |
2022―Aug―04 |
Non-productive exposure of
PBMCs
to
SARS-CoV
-2 induces cell-intrinsic innate immune responses |
Julia Kazmierski, Kirstin Friedmann, Dylan Postmus, Jackson Emanuel, Cornelius Fischer, Jenny Jansen, et al. (+11) Anja Richter, Laure Bosquillon de Jarcy, Christiane Schüler, Madlen Sohn, Sascha Sauer, Christian Drosten, Antoine-Emmanuel Saliba, Leif Erik Sander, Marcel A. Müller, Daniela Niemeyer, Christine Goffinet |
91 |
[GO] |
Molecular Systems Biology |
2022―May―17 |
Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants |
Diogo Pellegrina, Alexander T Bahcheli, Michal Krassowski, Jüri Reimand |
92 |
[GO] |
Molecular Systems Biology |
2022―Feb―14 |
High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein |
Rohit Suratekar, Pritha Ghosh, Michiel J M Niesen, Gregory Donadio, Praveen Anand, Venky Soundararajan, A J Venkatakrishnan |
93 |
[GO] |
Molecular Systems Biology |
2021―Dec―23 |
COVID-19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms |
Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert Phair, Aurelio Orta-Resendiz, et al. (+133) Vidisha Singh, Sara Sadat Aghamiri, Marcio Luis Acencio, Enrico Glaab, Andreas Ruepp, Gisela Fobo, Corinna Montrone, Barbara Brauner, Goar Frishman, Luis Cristóbal Monraz Gómez, Julia Somers, Matti Hoch, Shailendra Kumar Gupta, Julia Scheel, Hanna Borlinghaus, Tobias Czauderna, Falk Schreiber, Arnau Montagud, Miguel Ponce de Leon, Akira Funahashi, Yusuke Hiki, Noriko Hiroi, Takahiro G Yamada, Andreas Dräger, Alina Renz, Muhammad Naveez, Zsolt Bocskei, Francesco Messina, Daniela Börnigen, Liam Fergusson, Marta Conti, Marius Rameil, Vanessa Nakonecnij, Jakob Vanhoefer, Leonard Schmiester, Muying Wang, Emily E Ackerman, Jason E Shoemaker, Jeremy Zucker, Kristie Oxford, Jeremy Teuton, Ebru Kocakaya, Gökçe Yağmur Summak, Kristina Hanspers, Martina Kutmon, Susan Coort, Lars Eijssen, Friederike Ehrhart, D A B Rex, Denise Slenter, Marvin Martens, Nhung Pham, Robin Haw, Bijay Jassal, Lisa Matthews, Marija Orlic-Milacic, Andrea Senff-Ribeiro, Karen Rothfels, Veronica Shamovsky, Ralf Stephan, Cristoffer Sevilla, Thawfeek Varusai, Jean-Marie Ravel, Rupsha Fraser, Vera Ortseifen, Silvia Marchesi, Piotr Gawron, Ewa Smula, Laurent Heirendt, Venkata Satagopam, Guanming Wu, Anders Riutta, Martin Golebiewski, Stuart Owen, Carole Goble, Xiaoming Hu, Rupert W Overall, Dieter Maier, Angela Bauch, Benjamin M Gyori, John A Bachman, Carlos Vega, Valentin Grouès, Miguel Vazquez, Pablo Porras, Luana Licata, Marta Iannuccelli, Francesca Sacco, Anastasia Nesterova, Anton Yuryev, Anita de Waard, Denes Turei, Augustin Luna, Ozgun Babur, Sylvain Soliman, Alberto Valdeolivas, Marina Esteban-Medina, Maria Peña-Chilet, Kinza Rian, Tomáš Helikar, Bhanwar Lal Puniya, Dezso Modos, Agatha Treveil, Marton Olbei, Bertrand De Meulder, Stephane Ballereau, Aurélien Dugourd, Aurélien Naldi, Vincent Noël, Laurence Calzone, Chris Sander, Emek Demir, Tamas Korcsmaros, Tom C Freeman, Franck Augé, Jacques S Beckmann, Jan Hasenauer, Olaf Wolkenhauer, Egon L Willighagen, Alexander R Pico, Chris T Evelo, Marc E Gillespie, Lincoln D Stein, Henning Hermjakob, Peter D'Eustachio, Julio Saez-Rodriguez, Joaquin Dopazo, Alfonso Valencia, Hiroaki Kitano, Emmanuel Barillot, Charles Auffray, Rudi Balling, Reinhard Schneider |
94 |
[GO] |
Molecular Systems Biology |
2021―Oct―28 |
SARS-CoV-2-host proteome interactions for antiviral drug discovery |
Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, Taras Redchuk, Mariia Bogacheva, Kari Salokas, et al. (+10) Ina Pöhner, Tiina Öhman, Arun Kumar Tonduru, Antti Hassinen, Lisa Gawriyski, Salla Keskitalo, Maria K Vartiainen, Vilja Pietiäinen, Antti Poso, Markku Varjosalo |
95 |
[GO] |
Molecular Systems Biology |
2021―Oct―28 |
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets |
Kuoyuan Cheng, Laura Martin-Sancho, Lipika R Pal, Yuan Pu, Laura Riva, Xin Yin, et al. (+4) Sanju Sinha, Nishanth Ulhas Nair, Sumit K Chanda, Eytan Ruppin |
96 |
[GO] |
Molecular Systems Biology |
2021―Sep―14 |
SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms |
Seán I O’Donoghue, Andrea Schafferhans, Neblina Sikta, Christian Stolte, Sandeep Kaur, Bosco K Ho, et al. (+6) Stuart Anderson, James B Procter, Christian Dallago, Nicola Bordin, Matt Adcock, Burkhard Rost |
97 |
[GO] |
Molecular Systems Biology |
2021―Aug―13 |
Machine Learning Identifies Molecular Regulators and Therapeutics for Targeting SARS-CoV2-induced Cytokine Release |
Marina Chan, Siddharth Vijay, John McNevin, M. Juliana McElrath, Eric C. Holland, Taranjit S Gujral |
98 |
[GO] |
Molecular Systems Biology |
2021―Aug―02 |
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection |
Fangyuan Chen, Qingya Shi, Fen Pei, Andreas Vogt, Rebecca A Porritt, Gustavo Garcia, et al. (+10) Angela C Gomez, Mary Hongying Cheng, Mark E Schurdak, Bing Liu, Stephen Y Chan, Vaithilingaraja Arumugaswami, Andrew M Stern, D Lansing Taylor, Moshe Arditi, Ivet Bahar |
99 |
[GO] |
Molecular Systems Biology |
2021―Apr―27 |
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut |
Sergio Triana, Camila Metz-Zumaran, Carlos Ramirez, Carmon Kee, Patricio Doldan, Mohammed Shahraz, et al. (+8) Daniel Schraivogel, Andreas R Gschwind, Ashwini K Sharma, Lars M Steinmetz, Carl Herrmann, Theodore Alexandrov, Steeve Boulant, Megan L Stanifer |
100 |
[GO] |
Molecular Systems Biology |
2021―Feb―19 |
SARS-CoV-2 infection remodels the host protein thermal stability landscape |
Joel Selkrig, Megan Stanifer, André Mateus, Karin Mitosch, Inigo Barrio-Hernandez, Mandy Rettel, et al. (+14) Heeyoung Kim, Carlos G P Voogdt, Philipp Walch, Carmon Kee, Nils Kurzawa, Frank Stein, Clément Potel, Anna Jarzab, Bernhard Kuster, Ralf Bartenschlager, Steeve Boulant, Pedro Beltrao, Athanasios Typas, Mikhail M Savitski |
101 |
[GO] |
The EMBO Journal |
2022―Dec―15 |
Host range and structural analysis of bat-origin
RshSTT182
/200 coronavirus binding to human
ACE2
and its animal orthologs |
Yu Hu, Kefang Liu, Pu Han, Zepeng Xu, Anqi Zheng, Xiaoqian Pan, et al. (+11) Yunfei Jia, Chao Su, Lingfeng Tang, Lili Wu, Bin Bai, Xin Zhao, Tian Di, Zhihai Chen, Jianxun Qi, Qihui Wang, George F. Gao |
102 |
[GO] |
The EMBO Journal |
2022―Sep―26 |
Cyclin
D3
restricts
SARS-CoV
-2 Envelope incorporation into virions and interferes with viral spread. |
Ravi K. Gupta, Petra Mlcochova |
103 |
[GO] |
The EMBO Journal |
2022―Sep―20 |
Autophagy-linked plasma and lysosomal membrane protein
PLAC8
is a key host factor for
SARS-CoV
-2 entry into human cells |
Alejandro P. Ugalde, Gabriel Bretones, David Rodríguez, Víctor Quesada, Francisco Llorente, Raúl Fernández-Delgado, et al. (+13) Miguel Ángel Jiménez-Clavero, Jesús Vázquez, Enrique Calvo, Isaac Tamargo-Gómez, Guillermo Mariño, David Roiz-Valle, Daniel Maeso, Miguel Araujo-Voces, Yaiza Español, Carles Barceló, José M.P. Freije, Alejandro López-Soto, Carlos López-Otín |
104 |
[GO] |
The EMBO Journal |
2022―Jul―14 |
Attenuation of
SARS-CoV
-2 replication and associated inflammation by concomitant targeting of viral and host cap 2’-O-ribose methyltransferases |
Valter Bergant, Shintaro Yamada, Vincent Grass, Yuta Tsukamoto, Teresa Lavacca, Karsten Krey, et al. (+23) Maria-Teresa Mühlhofer, Sabine Wittmann, Armin Ensser, Alexandra Herrmann, Anja vom Hemdt, Yuriko Tomita, Shutoku Matsuyama, Takatsugu Hirokawa, Yiqi Huang, Antonio Piras, Constanze A. Jakwerth, Madlen Oelsner, Susanne Thieme, Alexander Graf, Stefan Krebs, Helmut Blum, Beate M. Kümmerer, Alexey Stukalov, Carsten B. Schmidt-Weber, Manabu Igarashi, Thomas Gramberg, Andreas Pichlmair, Hiroki Kato |
105 |
[GO] |
The EMBO Journal |
2022―Apr―26 |
Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19 |
Jennifer Becker, Ulrich Kalinke |
106 |
[GO] |
The EMBO Journal |
2022―Feb―18 |
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection |
Renée M. van der Sluis, Lamin B. Cham, Albert Gris-Oliver, Kristine R. Gammelgaard, Jesper G. Pedersen, Manja Idorn, et al. (+20) Ulvi Ahmadov, Sabina Sanches Hernandez, Ena Cémalovic, Stine H. Godsk, Jacob Thyrsted, Jesper D. Gunst, Silke D. Nielsen, Janni J. Jørgensen, Tobias Wang Bjerg, Anders Laustsen, Line S. Reinert, David Olagnier, Rasmus O. Bak, Mads Kjolby, Christian K. Holm, Martin Tolstrup, Søren R. Paludan, Lasse S. Kristensen, Ole S. Søgaard, Martin R. Jakobsen |
107 |
[GO] |
The EMBO Journal |
2022―Jan―04 |
Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin |
Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, et al. (+10) Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia, Chengpeng Qiao, Jianxun Qi, Wen-xia Tian, Hong-Wei Wang, Qihui Wang, George Fu Gao |
108 |
[GO] |
The EMBO Journal |
2021―Nov―15 |
SARS-CoV-2 variants as super cell fusers: cause or consequence of COVID-19 severity? |
Jana Koch, Zina M Uckeley, Pierre-Yves Lozach |
109 |
[GO] |
The EMBO Journal |
2021―Oct―04 |
SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation |
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Remy Robinot, Ludivine Grzelak, et al. (+12) Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers, Marija Zivaljic, Cyril Planchais, Florence Guivel-Benhassine, Françoise Porrot, Hugo Mouquet, Lisa A Chakrabarti, Julian Buchrieser, Olivier Schwartz |
110 |
[GO] |
The EMBO Journal |
2021―Sep―12 |
Infection and transmission of SARS-CoV-2 depends on heparan sulfate proteoglycans |
Marta Bermejo-Jambrina, Julia Eder, Tanja M. Kaptein, John L. van Hamme, Leanne C. Helgers, Killian E. Vlaming, et al. (+9) Philip J.M. Brouwer, Ad C. van Nuenen, Marcel Spaargaren, Godelieve J. de Bree, Bernadien M. Nijmeijer, Neeltje A. Kootstra, Marit J. van Gils, Rogier W. Sanders, Teunis B. H. Geijtenbeek |
111 |
[GO] |
The EMBO Journal |
2021―Aug―10 |
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites |
David Hoffmann, Stefan Mereiter, Yoo Jin Oh, Vanessa Monteil, Elizabeth Elder, Rong Zhu, et al. (+19) Daniel Canena, Lisa Hain, Elisabeth Laurent, Clemens Grünwald-Gruber, Miriam Klausberger, Gustav Jonsson, Max J. Kellner, Maria Novatchkova, Melita Ticevic, Antoine Chabloz, Gerald Wirnsberger, Astrid Hagelkruys, Friedrich Altmann, Lukas Mach, Johannes Stadlmann, Chris Oostenbrink, Ali Mirazimi, Peter Hinterdorfer, Josef M. Penninger |
112 |
[GO] |
The EMBO Journal |
2021―Jul―29 |
A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein |
Anna Albecka, Dean Clift, Marina Vaysburd, Tyler Rhinesmith, Sarah L Caddy, David M Favara, et al. (+2) Helen E Baxendale, Leo C James |
113 |
[GO] |
The EMBO Journal |
2021―Jul―24 |
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies |
Thomas Güttler, Metin Aksu, Antje Dickmanns, Kim M. Stegmann, Kathrin Gregor, Renate Rees, et al. (+12) Waltraud Taxer, Oleh Rymarenko, Jürgen Schünemann, Christian Dienemann, Philip Gunkel, Bianka Mussil, Jens Krull, Ulrike Teichmann, Uwe Groß, Volker C. Cordes, Matthias Dobbelstein, Dirk Görlich |
114 |
[GO] |
The EMBO Journal |
2021―Jul―23 |
SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage |
Juan Ma, Fangrui Zhu, Min Zhao, Fei Shao, Dou Yu, Jiangwen Ma, et al. (+7) Xusheng Zhang, Weitao Li, Yan Qian, Yan Zhang, Dong Jiang, Shuo Wang, Pengyan Xia |
115 |
[GO] |
The EMBO Journal |
2021―Jul―07 |
Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis |
Zhen Chen, Chao Wang, Xu Feng, Litong Nie, Mengfan Tang, Huimin Zhang, et al. (+4) Yun Xiong, Samuel K. Swisher, Mrinal Srivastava, Junjie Chen |
116 |
[GO] |
The EMBO Journal |
2021―Jun―23 |
TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells |
Jana Koch, Zina M Uckeley, Patricio Doldan, Megan Stanifer, Steeve Boulant, Pierre-Yves Lozach |
117 |
[GO] |
The EMBO Journal |
2021―Jun―08 |
SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation |
Lucy G Thorne, Ann-Kathrin Reuschl, Lorena Zuliani-Alvarez, Matthew V.X. Whelan, Jane Turner, Mahdad Noursadeghi, et al. (+2) Clare Jolly, Greg J Towers |
118 |
[GO] |
The EMBO Journal |
2021―May―21 |
Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin |
Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, et al. (+10) Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia, Chengpeng Qiao, Jianxun Qi, Wen-xia Tian, Hong-Wei Wang, Qihui Wang, George Fu Gao |
119 |
[GO] |
The EMBO Journal |
2021―Apr―21 |
The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation |
Jian Lei, Yue Ma-Lauer, Yinze Han, Matthias Thoms, Robert Buschauer, Joerg Jores, et al. (+6) Volker Thiel, Roland Beckmann, Wen Deng, Heinrich Leonhardt, Rolf Hilgenfeld, Albrecht von Brunn |
120 |
[GO] |
The EMBO Journal |
2021―Feb―14 |
Halting SARS-CoV-2: lung organoids step up to the plate |
Sandra L Leibel, Xin Sun |
121 |
[GO] |
The EMBO Journal |
2021―Feb―01 |
Syncytia formation by SARS-CoV-2-infected cells |
Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, et al. (+8) Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf, Nicoletta Casartelli, Hugo Mouquet, Timothée Bruel, Olivier Schwartz |
122 |
[GO] |
The EMBO Journal |
2020―Dec―07 |
An Organoid-derived Bronchioalveolar Model for SARS-CoV-2 Infection of Human Alveolar-type II-like Cells |
Mart M. Lamers, Jelte van der Vaart, Kèvin Knoops, Samra Riesebosch, Tim I. Breugem, Anna Z. Mykytyn, et al. (+14) Joep Beumer, Debby Schipper, Karel Bezstarosti, Charlotte D. Koopman, Nathalie Groen, Raimond B.G. Ravelli, Hans Q. Duimel, Jeroen A.A. Demmers, Georges M.G.M. Verjans, Marion P.G. Koopmans, Mauro J. Muraro, Peter J. Peters, Hans Clevers, Bart L. Haagmans |
123 |
[GO] |
The EMBO Journal |
2020―Dec―03 |
Opposing activities of IFITM proteins in SARS-CoV-2 infection |
Guoli Shi, Adam D. Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, et al. (+5) Luanne Hall-Stoodley, Richard T. Robinson, Dmitri S. Kudryashov, Alex A. Compton, Jacob S. Yount |
124 |
[GO] |
The EMBO Journal |
2020―Nov―17 |
SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs |
Theodora Myrto Perdikari, Anastasia C. Murthy, Veronica H. Ryan, Scott Watters, Mandar T. Naik, Nicolas L. Fawzi |
125 |
[GO] |
The EMBO Journal |
2020―Nov―11 |
COVID-19 lessons from the dish: Dissecting CNS manifestations through brain organoids |
Nicolò Caporale, Giuseppe Testa |
126 |
[GO] |
The EMBO Journal |
2020―Nov―03 |
Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage |
Yan-Mei Chen, Yuanting Zheng, Ying Yu, Yunzhi Wang, Qingxia Huang, Feng Qian, et al. (+21) Lei Sun, Zhi-Gang Song, Ziyin Chen, Jinwen Feng, Yanpeng An, Jingcheng Yang, Zhenqiang Su, Shanyue Sun, Fahui Dai, Qinsheng Chen, Qinwei Lu, Pengcheng Li, Yun Ling, Zhong Yang, Huiru Tang, Leming Shi, Li Jin, Edward C. Holmes, Chen Ding, Tong-Yu Zhu, Yong-Zhen Zhang |
127 |
[GO] |
The EMBO Journal |
2020―Oct―14 |
Syncytia formation by SARS-CoV-2 infected cells |
Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, et al. (+8) Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf, Nicoletta Casartelli, Hugo Mouquet, Timothée Bruel, Olivier Schwartz |
128 |
[GO] |
The EMBO Journal |
2020―Sep―22 |
Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design |
Ya Peng, Ning Du, Yuqing Lei, Sonam Dorje, Jianxun Qi, Tingrong Luo, et al. (+2) George F Gao, Hao Song |
129 |
[GO] |
The EMBO Journal |
2020―Sep―22 |
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells |
Soeren Lukassen, Robert Lorenz Chua, Timo Trefzer, Nicolas C Kahn, Marc A Schneider, Thomas Muley, et al. (+8) Hauke Winter, Michael Meister, Carmen Veith, Agnes W Boots, Bianca P Hennig, Michael Kreuter, Christian Conrad, Roland Eils |
130 |
[GO] |
The EMBO Journal |
2020―Sep―18 |
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and coronaviruses by depleting membrane cholesterol |
Shaobo Wang, Wanyu Li, Hui Hui, Shashi Kant Tiwari, Qiong Zhang, Ben A. Croker, et al. (+4) Stephen Rawlings, Davey Smith, Aaron F. Carlin, Tariq M. Rana |
131 |
[GO] |
The EMBO Journal |
2020―Sep―02 |
SARS-CoV-2 targets neurons of 3D human brain organoids |
Anand Ramani, Lisa Müller, Philipp Niklas Ostermann, Elke Gabriel, Pranty Abida-Islam, Andreas Müller-Schiffmann, et al. (+17) Aruljothi Mariappan, Olivier Goureau, Henning Gruell, Andreas Walker, Marcel Andrée, Sandra Hauka, Torsten Houwaart, Alexander Dilthey, Kai Wohlgemuth, Heymut Omran, Florian Klein, Dagmar Wieczorek, Ortwin Adams, Jörg Timm, Carsten Korth, Heiner Schaal, Jay Gopalakrishnan |
132 |
[GO] |
The EMBO Journal |
2020―Aug―26 |
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2 |
Theresa Klemm, Gregor Ebert, Dale J Calleja, Cody C Allison, Lachlan W Richardson, Jonathan P Bernardini, et al. (+23) Bernadine GC Lu, Nathan W Kuchel, Christoph Grohmann, Yuri Shibata, Zhong Yan Gan, James P Cooney, Marcel Doerflinger, Amanda E Au, Timothy R Blackmore, Gerbrand J Heden van Noort, Paul P Geurink, Huib Ovaa, Janet Newman, Alan Riboldi-Tunnicliffe, Peter E Czabotar, Jeffrey P Mitchell, Rebecca Feltham, Bernhard C Lechtenberg, Kym N Lowes, Grant Dewson, Marc Pellegrini, Guillaume Lessene, David Komander |
|